Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Felix

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 1, 2015
Pharmacovigilance Considerations for Biosimilars in the USAGustavo Grampp, Thomas Felix
Journal of Visualized Experiments : Jove|November 20, 2014
Universal hand-held three-dimensional optoacoustic imaging probe for deep tissue human angiography and functional preclinical studies in real timeXosé Deán-Ben, Thomas Felix Fehm, Daniel Razansky
Journal of Clinical Hypertension (Greenwich, Conn.)|March 26, 2018
Renal nerve ablation reduces blood pressure in resistant hypertension: Long-term clinical outcomes in a single-center experienceAndrea Denegri, Tino Naduvathumuriyil, Thomas Felix Lüscher, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Managing the Risks of Medicines: An Examination of FDA's Application of Criteria for Requiring a REMSPaul J Seligman, Rebekah H Anguiano, Thomas Felix, et al.
Scientific Reports|July 30, 2025
Assessing the socioeconomic and environmental determinants of flood vulnerability in India: a panel data approachKannan Thomas Felix, M Balasubramanian, Padma Lakshmi Govindarajan, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 9, 2014
Similar names for similar biologicsNicole Casadevall, Thomas Felix, Bruce E Strober, et al.
Expert Opinion on Drug Safety|February 5, 2019
Current state of biologic pharmacovigilance in the European Union: improvements are neededThomas Felix, John B Jordan, Catherine Akers, et al.
Atherosclerosis|October 1, 2013
Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspectiveFrancesco Paneni, Sarah Costantino, Massimo Volpe, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 15, 2015
Noninvasive real-time visualization of multiple cerebral hemodynamic parameters in whole mouse brains using five-dimensional optoacoustic tomographySven Gottschalk, Thomas Felix Fehm, Xosé Luís Deán-Ben, et al.
Drug Safety|September 18, 2016
A Survey of Adverse Event Reporting Practices Among US Healthcare ProfessionalsStella Stergiopoulos, Carrie A Brown, Thomas Felix, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 1, 2015
Pharmacovigilance Considerations for Biosimilars in the USAGustavo Grampp, Thomas Felix
Journal of Visualized Experiments : Jove|November 20, 2014
Universal hand-held three-dimensional optoacoustic imaging probe for deep tissue human angiography and functional preclinical studies in real timeXosé Deán-Ben, Thomas Felix Fehm, Daniel Razansky
Journal of Clinical Hypertension (Greenwich, Conn.)|March 26, 2018
Renal nerve ablation reduces blood pressure in resistant hypertension: Long-term clinical outcomes in a single-center experienceAndrea Denegri, Tino Naduvathumuriyil, Thomas Felix Lüscher, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Managing the Risks of Medicines: An Examination of FDA's Application of Criteria for Requiring a REMSPaul J Seligman, Rebekah H Anguiano, Thomas Felix, et al.
Scientific Reports|July 30, 2025
Assessing the socioeconomic and environmental determinants of flood vulnerability in India: a panel data approachKannan Thomas Felix, M Balasubramanian, Padma Lakshmi Govindarajan, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 9, 2014
Similar names for similar biologicsNicole Casadevall, Thomas Felix, Bruce E Strober, et al.
Expert Opinion on Drug Safety|February 5, 2019
Current state of biologic pharmacovigilance in the European Union: improvements are neededThomas Felix, John B Jordan, Catherine Akers, et al.
Atherosclerosis|October 1, 2013
Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspectiveFrancesco Paneni, Sarah Costantino, Massimo Volpe, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 15, 2015
Noninvasive real-time visualization of multiple cerebral hemodynamic parameters in whole mouse brains using five-dimensional optoacoustic tomographySven Gottschalk, Thomas Felix Fehm, Xosé Luís Deán-Ben, et al.
Drug Safety|September 18, 2016
A Survey of Adverse Event Reporting Practices Among US Healthcare ProfessionalsStella Stergiopoulos, Carrie A Brown, Thomas Felix, et al.
Pageof 5